Article
Is BRCA Mutation Testing Cost Effective for Early Stage Breast Cancer Patients Compared to Routine Clinical Surveillance? The Case of an Upper Middle-Income Country in Asia.
Applied health economics and health policy - 1 Jun 2018
Lim Ka Keat, Yoon Sook Yee, Mohd Taib Nur Aishah, Shabaruddin Fatiha Hana, Dahlui Maznah, Woo Yin Ling, Thong Meow Keong, Teo Soo Hwang, Chaiyakunapruk Nathorn
Abstract excerpt
OBJECTIVE: Previous studies showed that offering BRCA mutation testing to population subgroups at high risk of harbouring the mutation may be cost effective, yet no evidence is available for low- or middle-income countries (LMIC) and in Asia. We estimated the cost effectiveness of BRCA mutation testing in early-stage breast cancer patients with high pre-test probability of harbouring the mutation in Malaysia, an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.